CBFV
CB Financial Services, Inc.
CBFV has slightly lower modeled downside risk, despite its lower overall score.
MS
Morgan Stanley
MS has a slight edge over CBFV overall, supported by stronger valuation.
CBFV Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CBFV's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CBFV.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CBFV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $24.21 | -41% |
| Fair | 9.8x | $33.63 | -18% |
| Current | 12x | $41.10 | — |
| Forward | 12x | $41.10 | — |
| Expensive | 20x | $67.40 | +64% |
Historical ranges are pointers, not guarantees.
CBFV has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CBFV Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CBFV, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over CBFV on the outlook, with more favorable valuation expectations.
CBFV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.36 | -1.7% |
| Q3 2026 | $3.42 | +628% |
| Q2 2026 | $1.36 | -36% |
| Q1 2026 | $1.30 | -32% |
| Q4 2025 | $0.92 | -61% |
| Q3 2025 | $0.47 | -89% |
| Q2 2025 | $2.14 | -51% |
| Q1 2025 | $1.91 | -57% |
| Q4 2024 | $2.38 | -46% |
CBFV earned $3.42 per share over the past year, about seven times what it earned the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over CBFV on earnings, with more consistent year-over-year improvement.
CBFV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16M | +561% |
| Q2 2026 | $15.5M | +15% |
| Q1 2026 | $14.8M | +23% |
| Q4 2025 | $15.6M | +18% |
| Q3 2025 | $2.4M | -81% |
| Q2 2025 | $13.5M | +11% |
| Q1 2025 | $12.1M | -10% |
| Q4 2024 | $13.2M | -52% |
CBFV's revenue is recovering but still below its 2023 peak: $16M last quarter, up 561% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +326 points |
| Q2 2026 | 33% | -2.1 points |
| Q1 2026 | 31% | +12 points |
| Q4 2025 | 34% | +11 points |
| Q3 2025 | -290% | -321 points |
| Q2 2025 | 35% | +8.6 points |
| Q1 2025 | 19% | -19 points |
| Q4 2024 | 23% | -43 points |
CBFV has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over CBFV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
CBFV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.8M | -161% |
| Q2 2026 | $7.4M | +90% |
| Q1 2026 | $2.8M | -28% |
| Q4 2025 | $4.8M | +267% |
| Q3 2025 | $4.5M | +104% |
| Q2 2025 | $3.9M | +$6.3M |
| Q1 2025 | $3.9M | +71% |
| Q4 2024 | $1.3M | +$6.4M |
CBFV has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
CBFV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +4.1K shares |
| 1 year | +0.7% | +38.5K shares |
| 3 years | +4.5% | +232K shares |
| 5 years | -0.6% | -32.1K shares |
| Available history | -1.7% | -90.7K shares |
CBFV has 5M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9,000 |
| Q2 2026 | $14,000 |
| Q1 2026 | $292,000 |
| Q4 2025 | $14,000 |
| Q3 2025 | $7,000 |
| Q2 2025 | $4.4M |
| Q1 2025 | $2.4M |
| Q4 2024 | $634,000 |
CBFV spent $329,000 buying back its own shares over the past year, down 96% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over CBFV on shareholder dilution, with a more favorable share count trend.
CBFV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | 5.4x | High |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
CBFV has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
CBFV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 89.3 | Overbought |
CBFV's weekly RSI is 71 (overbought) and its Stochastic is 89 (overbought).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CBFV PE vs Financial Services Sector
| Metric | CBFV | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.7% below |
| PE % | 63 | 63 | Same percentile |
CBFV has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
CBFV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 6.5% above |
| 20 week MA | $37.7 | 8.9% above |
| 50 week MA | $36.4 | 13% above |
| 100 week MA | $33.3 | 23% above |
| 200 week MA | $28.3 | 45% above |
CBFV has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
CBFV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.6 | $20.3 | -34% |
| 2021 | $20.3 | $23.9 | +18% |
| 2022 | $23.9 | $21.3 | -11% |
| 2023 | $21.3 | $23.8 | +12% |
| 2024 | $23.8 | $28.7 | +20% |
| 2025 | $28.7 | $36.0 | +25% |
| 2026 YTD | $36.0 | $41.1 | +14% |
CBFV has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.